================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of earliest event reported: July 7, 2005,
QLT INC.
-----------------------------------------
(Exact Name of Registrant as Specified in Charter)
British Columbia, Canada 000-17082 N/A
- ---------------------------- ------------------------ -------------------
(State or Other Jurisdiction (Commission File Number) (I.R.S. Employer
of Incorporation) Identification No.)
887 Great Northern Way, Vancouver, B.C. Canada, V5T 4T5
-------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(604) 707-7000
----------------------------------------------------
(Registrant's telephone number, including area code)
Not Applicable
-------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 8.01 OTHER EVENTS
On July 7, 2005, QLT Inc. ("QLT") issued a press release announcing
that it received final approval from the U.S. Food and Drug Administration (FDA)
to market ACZONE(TM) (dapsone) Gel, 5% for the topical treatment of acne
vulgaris.
The full text of the press release is attached hereto as Exhibit 99.1
to this Current Report on Form 8-K and is incorporated herein by reference.
Number Description
- ------ -----------
99.1 Press Release issued by QLT Inc. on July 7, 2005.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
QLT INC.
(Registrant)
By: /s/ Paul J. Hastings
---------------------------------------
Paul J. Hastings
President and Chief Executive Officer
Dated: July 7, 2005
EXHIBIT 99.1